CakeResume Talent Search

BioSig Technologies The Los Angeles-based medical device company BioSig Technologies , focuses on developing a patented biomedical signal processing technology designed to improve Atrial Fibrillation. A proven management team and a veteran and independent Board of Directors is leading this company. The PURE EP System is the company’s first product. This is a technology which has been developed with the aim to address an unmet need in a large and growing market. The PURE EP System is a novel cardiac signal acquisition and visualization system which was designed to assist electrophysiologists in clinical decision making

Kenneth Londoner Kenneth Londoner is the founder of BioSig Technologies, a medical device company. He also serves as its CEO and Chairman. This company has developed the PURE EP System. This system aims to provide more accurate treatment to patients suffering from Atrial Fibrillation and Complex Arrhythmia. Kenneth Londoner has over three decades long experience which encompasses general management and marketing. He dedicated to assisting a number of emerging growth companies in their corporate development and investing needs. Londoner holds a Bachelor’s Degree in economics and finance from the Lafayette College in Easton